Skip to content

Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02100293
Enrollment
84
Registered
2014-03-31
Start date
2013-10-31
Completion date
2014-12-31
Last updated
2016-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation Condition, Observation of Neuromuscular Block, Surgical Condition

Keywords

magnesium sulfate, rocuronium

Brief summary

This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose rocuronium, intubation condition and surgical condition.

Interventions

DRUGmagnesium sulfate 30 mg/kg

Patients in each group received the magnesium sulfate 30 mg/kg for 2 min in 0.9% normal saline (total volume 100 ml) intravenously for 5 min before induction of anesthesia

DRUGsaline

Patients in each group received 0.9% normal saline (total volume 100 ml) alone intravenously for 5 min before induction of anesthesia

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 18-75 yr American Society of Anesthesiologists physical status 1 or 2, BMI of 20-24.9 kg/m2 scheduled for elective laryngeal microsurgery

Exclusion criteria

* severe respiratory or cardiac disease hepatic or renal function impairment neuromuscular disease on medications affecting neuromuscular function with known allergy to the drugs

Design outcomes

Primary

MeasureTime frameDescription
onset time of rocuroniumfrom injection of rocuronium to T1 suppression more than 95% up to 10 minutesfrom injection of rocuronium to T1 suppression more than 95% up to 10 minutes

Secondary

MeasureTime frame
maximal suppression time and duration of rocuroniumtime from the injection of rocuronium to T1 maximal suppression time and reversal of T1 25% up to 1 hours

Other

MeasureTime frameDescription
intubation conditionintubation condition during induction of anesthesia up to 10 minutesWe scored intubation condition on the basis of 4 items, laryngoscopy, vocal cord position, moving of limbs, and coughing.
surgical conditionintraoperative surgical conditionto score a surgical condition according to 7 point likers scale
postoperative sore throatpostoperative sore throat up to 4 hours

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026